Back to Search Start Over

Oxidized Phospholipid oxPAPC Alters Regulatory T-Cell Differentiation and Decreases Their Protective Function in Atherosclerosis in Mice.

Authors :
Appleton BD
Palmer SA
Smith HP
Stephens LE
Major AS
Source :
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2023 Nov; Vol. 43 (11), pp. 2119-2132. Date of Electronic Publication: 2023 Sep 07.
Publication Year :
2023

Abstract

Background: Regulatory T cells (T <subscript>regs</subscript> ) are protective in atherosclerosis but reduced during disease progression due to cell death and loss of stability. However, the mechanisms of T <subscript>reg</subscript> dysfunction remain unknown. Oxidized phospholipids are abundant in atherosclerosis and can activate innate immune cells, but little is known regarding their impact on T cells. Given T <subscript>reg</subscript> loss during atherosclerosis progression and oxidized phospholipid levels in the plaque microenvironment, we investigated whether oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (oxPAPC), an oxidized phospholipid associated with atherosclerotic plaques, alters T <subscript>reg</subscript> differentiation and function.<br />Methods: CD4 <superscript>+</superscript> T cells were polarized to T <subscript>reg</subscript> , T helper (Th) 1, and Th17 cells with or without oxPAPC and assessed by flow cytometry. Gene expression in oxPAPC-treated T <subscript>regs</subscript> was analyzed by bulk RNA sequencing. Functional studies of oxPAPC-induced T <subscript>regs</subscript> were performed by coculturing T <subscript>regs</subscript> with CellTrace Violet-labeled cells in vitro, and by adoptively transferring T <subscript>regs</subscript> to hyperlipidemic Ldlr <superscript> -/- </superscript> mice to measure atherosclerosis progression.<br />Results: Compared with controls, oxPAPC-treated T <subscript>regs</subscript> were less viable, but surviving cells expressed higher levels of the Th1-associated markers T-bet, CXCR3, and IFN (interferon)-γ. Th1 and Th17 skewing cultures were unaltered by oxPAPC. IFN-γ is linked to T <subscript>reg</subscript> instability, thus T <subscript>reg</subscript> polarization experiments were repeated using Ifngr1 <superscript> -/- </superscript> CD4 <superscript>+</superscript> T cells. IFNγR1 (INF gamma receptor 1) deficiency did not improve cell viability in oxPAPC-treated T <subscript>regs</subscript> ; however, T-bet and IFN-γ expression was not increased in surviving cells suggesting a role for IFN-γsignaling. OxPAPC-treated T <subscript>regs</subscript> were less suppressive in vitro, and adoptive transfer studies in hyperlipidemic Ldlr <superscript> -/- </superscript> mice showed that oxPAPC-induced T <subscript>regs</subscript> possessed altered tissue homing and were insufficient to inhibit atherosclerosis progression.<br />Conclusions: OxPAPC elicits T <subscript>reg</subscript> -specific changes altering T <subscript>reg</subscript> differentiation and inducing a Th1-like phenotype in surviving cells partially through IFN-γ signaling. This is biologically relevant as oxPAPC-treated T <subscript>regs</subscript> do not reduce atherosclerosis progression in Ldlr <superscript> -/- </superscript> mice. This study supports the role of oxidized phospholipids in negatively impacting T <subscript>reg</subscript> differentiation and atheroprotective function.<br />Competing Interests: Disclosures None.

Details

Language :
English
ISSN :
1524-4636
Volume :
43
Issue :
11
Database :
MEDLINE
Journal :
Arteriosclerosis, thrombosis, and vascular biology
Publication Type :
Academic Journal
Accession number :
37675632
Full Text :
https://doi.org/10.1161/ATVBAHA.123.319674